Sign in

CIK 0001631574

  • Large accelerated filer

Wave Life Sciences, Inc.

Sign in to watch
Ticker
WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2900
Business address
733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
Former names
Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Francis Chris sold 24,496 shares at an average $37.27 ($913,054)
  7. 4 Open-market sale Francis Chris sold 48,992 shares at an average $46.75 ($2,290,376)
  8. 4 Open-market sale President and CEO sold 31,711 shares at $45.00 ($1,426,995)
  9. 4 Open-market sale President and CEO sold 18,289 shares at $45.00 ($823,005)
  10. 4 Open-market sale Francis Chris sold 21,639 shares at an average $55.40 ($1,198,760)
  11. 4 Open-market sale President and CEO sold 2,714 shares at an average $51.50 ($139,783)
  12. 4 Open-market sale Franchise Lead, Neurology sold 511 shares at $52.10 ($26,623)
  13. 4 Open-market sale Chief Financial Officer sold 316 shares at $51.85 ($16,385)
  14. 4 Open-market sale Vargeese Chandra sold 2,000 shares at $50.00 ($100,000)
  15. 4 Open-market sale Franchise Lead, Neurology sold 18,750 shares at $50.00 ($937,500)
  16. 5 Insider Annual Insider Trading Report
  17. 4 Open-market sale Vargeese Chandra sold 2,000 shares at $40.00 ($80,000)
  18. 4 Grant or award Francis Chris acquired 13,000 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 13,000 shares (grant or award)
  20. 4 Grant or award Franchise Lead, Neurology acquired 17,500 shares (grant or award)

Page 11 of 14 · 274 filings